Skip to main content
REMED CO.,LTD. logo

REMED CO.,LTD. — Investor Relations & Filings

Ticker · 302550 ISIN · KR7302550009 KO Manufacturing
Filings indexed 350 across all filing types
Latest filing 2026-05-20 Transaction in Own Shar…
Country KR South Korea
Listing KO 302550

About REMED CO.,LTD.

https://www.remed.kr/en/

REMED CO.,LTD. is a medical device company specializing in the research, development, and manufacturing of electronic medication, also known as electroceuticals. The company focuses on providing non-invasive treatment solutions for intractable brain diseases, rehabilitation, and pain management. Its core technologies include transcranial magnetic stimulation (TMS) for neural modulation, as well as advanced electromagnetic stimulation, shockwave, and laser therapies. REMED produces both complete medical systems and essential core components, positioning itself as a provider of differentiated solutions in the medical technology sector.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 88% confidence The document is a ‘주요사항보고서(자기주식취득 신탁계약 체결 결정)’ – a material event report announcing the board’s decision to enter into a trust contract for acquiring treasury shares. It details contract amounts, periods, trustee, expected share counts and prices, and the company’s current and projected treasury stock positions. This clearly falls under a share repurchase/own-shares transaction, matching our “Transaction in Own Shares” category.
2026-05-20 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 89% confidence The document is a ‘신탁계약해지결과보고서’ submitted to the Financial Supervisory Service detailing the termination of a trust contract established to acquire the company’s own shares, with tables showing self-share acquisition/disposal amounts and holdings. This is a report on a share repurchase arrangement via trust. Therefore it falls under “Transaction in Own Shares” (Code: POS).
2026-05-20 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 90% confidence The document is a Korean regulatory ‘주요사항보고서’ disclosing the termination of a trust agreement for the acquisition of treasury shares and the return of repurchased own shares. This is a detailed announcement of a share repurchase transaction (termination of a trust repurchase arrangement and return of shares), which fits the “Transaction in Own Shares” category.
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document title and contents clearly identify it as a Korean '분기보고서' covering the period 2026-01-01 to 2026-03-31 and labelled as the 24th fiscal quarter. It includes full financial statements, detailed disclosures on business overview, capital changes, production data, and actual financial results for the quarter. This matches the definition of an Interim/Quarterly Report rather than an announcement or summary. Therefore, it should be classified under code IR (Interim / Quarterly Report). Q1 2026
2026-05-14 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 99% confidence The document is a regulatory report to the Financial Supervisory Service detailing the company’s acquisition of its own shares via a trust contract (including dates, quantities, prices, and post-acquisition shareholding). This matches the definition of a Transaction in Own Shares (share repurchase) in our taxonomy.
2026-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(일반)' which translates to 'Report on Large Shareholding Status (General)'. It contains detailed information about the number of shares held, shareholding ratios, changes in shareholding, and related contracts such as stock collateral loans. The document references specific dates and includes detailed tables about share ownership by individuals and related parties. This type of document corresponds to notifications about major shareholding changes or disclosures of significant share ownership levels. It is not an annual report, earnings release, or management report, nor is it a proxy statement or voting result announcement. The content fits the definition of a Major Shareholding Notification (MRQ). The document length is over 10,000 characters and contains substantive data, so it is not a mere announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2026-05-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.